Combination of a dopamine agonist, MAO-B inhibitor and levodopa - a new strategy in the treatment of early Parkinson's disease-Reference-Cited by-同舟云学术

Combination of a dopamine agonist, MAO-B inhibitor and levodopa - a new strategy in the treatment of early Parkinson's disease

Published:1989-11 Issue: Volume:80 Page:165-169
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Rinne U. K.

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.1989.tb01797.x/fullpdf

Reference19 articles.

1. Long-term treatment of parkinsonism with L-dopa and decarboxylase inhibitor: a clinical and biochemical approach;Rinne;Switzerland Editiones Roche,1976

2. Treatment of Parkinson's disease: problems with progressing disease;Rinne;J Neural Transm,1981

3. Problems associated with long-term levodopa treatment of Parkinson's disease;Rinne;Acta Neurol Scand (Suppl 95),1983

4. Combined bromocriptine-levodopa therapy early in Parkinson's disease;Rinne;Neurology,1985

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease;Advances in Therapy;2022-03-10

2. Chromenylchalcones with inhibitory effects on monoamine oxidase B;Bioorganic & Medicinal Chemistry;2013-12

3. The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients;Acta Neurologica Scandinavica;2005-02

4. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment;Neurotoxicity Research;2003-01

5. Parkinsonism;Neurological Disorders;2003